澳门赌场招聘-赌场有哪些_免费百家乐追号软件_全讯网最新资讯网址 (中国)·官方网站

On Campus

Team SYSU-MEDICINE from Zhongshan School of Medicine, SYSU, Won the Gold Medal and Two Best Awards in iGEM, 2016

Share
  • Updated: Nov 4, 2016
  • Written:
  • Edited:

Source: Zhongshan School of Medicine
Written by: Zhongshan School of Medicine
Edited by: Wang Dongmei

On October 31st, 2016, the International Genetically Engineered Machine Competition (iGEM) came to an end. This year, SYSU-MEDICINE, the team from Zhongshan School of Medicine of Sun Yat-sen University (SYSU), instructed by Professor Xiang Peng and Dr. Wang Jiancheng, won a number of prizes, including Best Therapeutics Project, Best New Composite Part, nominated for Best Model and a Gold Medal.

iGEM is a top international competition in the field of synthetic biology. With great international influence, the competition attracts great attention all over the world and is reported by Nature, Science, Scientific American, Economists, BBC and other mainstream media each year. In 2016, 306 teams around the world participated in the competition, including teams from Harvard, MIT, Stanford, Oxford and other famous universities. It is the first time for SYSU-MEDICINE to take part in iGEM competition, defeat powerful opponents and achieve great success.
 

 

The SYSU-MEDICINE iGEM team
 

Under the great support of Zhongshan School of Medicine, 14 undergraduates (Zhou Longyuan, Su Xiaojun, Chen Qinchang, Huang Zhipei, Zhang Zhiqian, Yuan Meng, Huang Yinong, Wu Haoxiang, Li Tong, Li Qihao, Bai Yang, Lang Quanjun, Li Xin and Fang Xueyu) from different schools of SYSU, including Zhongshan School of Medicine, School of Public Health, School of Mathematics, School of Data and Computer Science, and School of Communication and Design, formed the SYSU-MEDICINE iGEM team. Supervised by Prof. Xiang Peng and Dr. Wang Jiancheng, the team focused on the challenging scientific problem "precise targeted therapy of mesenchymal stem cells (MSCs)" and started carrying out the project "MSCavalry: MSCs of Next Generation", including biobricks construction, animal model validation, human practices, mathematical modeling, art design and website establishment. The chemokine receptors engineered MSCs will smartly home to the injured tissues and significantly alleviate the syndromes, which may provide novel and promising therapeutic strategy.

The competition not only demonstrates the excellent medical education of SYSU, but also vividly fulfilled the teaching philosophy----SYSU students should have both talent and moral integrity, ability to cultivate charisma of leadership and eagerness to serve their country.

This project was supported by Mr. Xu Jianping, an alumnus of Zhongshan School of Medicine in 1980.

Wiki link: http://2016.igem.org/Team:SYSU-MEDICINE

Background of iGEM:

The International Genetically Engineered Machine (iGEM) was founded in 2003 by the Massachusetts Institute of Technology (MIT), and was developed into an international event in 2005. It aimed at encouraging students all over the world to communicate and cooperate, to learn about synthetic biology and promote synthetic biology.

In 2016, more than 300 teams around the world participated in iGEM, including Harvard, MIT, Cambridge, Oxford, Stanford University and other world famous universities. In addition, Tokyo University, Peking University, Tsinghua University, Fudan University, Shanghai Jiao Tong University, Sun Yat-sen University and other Asian famous universities were involved.

Synthetic biology has emerged in 21st century. It is an interdisciplinary branch of biology and engineering and combines various disciplines from within these domains, such as biotechnology, evolutionary biology, genetic engineering, molecular biology, molecular engineering, systems biology, biophysics and computer engineering. It aims to achieve the signal processing and precious control of the engineering organisms. iGEM has become the top competition of synthetic biology for students worldwide. Each year, the competition is reported by Nature, Science, Scientific American, Economists, BBC and other mainstream media, which has a huge international influence.

Best Therapeutics Project: No.1 of all teams in Therapeutics Track.

Best New Composite Part: No.1 of all teams in the field of new composite part construction.

Nominated for Best Model: Top 6 of all teams in the field of mathematical model.

Gold Medal: Meet the standards of Gold Modal. (Number of teams is not limited.)


TOP
百家乐官网这样赢保单分析 | 威尼斯人娱乐代理注| 梭哈棋牌游戏大厅| 折式百家乐官网赌台| 百家乐官网技巧论坛| 偃师市| A8百家乐官网娱乐场| 百家乐制胜方法| 百家乐赌博破解| 辽阳市| 百家乐官网赌场讨论群| 百家乐衬衣| 北京市| 新澳门百家乐软件下载| 平远县| 24山阴宅评凶吉| 百家乐投注网站| 百家乐筹码托盘| 德州扑克牌| 百家乐官网娱乐网址| 赌博百家乐官网秘籍| 百家乐赚水方| 大发888真人网址的微博| 缅甸百家乐官网玩假吗| 逍遥坊百家乐的玩法技巧和规则| 互博百家乐现金网| 澳门玩百家乐00| 百家乐官网新台第二局| 百家乐官网楼梯缆| 澳门百家乐娱乐网| 百家乐官网真人娱乐城| 在线百家乐大家赢| 阿拉善右旗| 鹤庆县| 做生意摆放什么财神爷| 百家乐去哪里玩最好| 百家乐官网网站加盟| 百家乐注册送10彩金| 陈巴尔虎旗| 百家乐必胜法技巧| 赌博中百家乐什么意思|